
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    Okay, let's analyze this list of highly expressed genes from a single-cell cluster in human large intestine tissue to identify the cell type.<br><br>**Step 1: List the Key Functional Markers**<br><br>This list is overwhelmingly enriched for genes involved in cell cycle progression, DNA replication, and mitosis. Let's group some of the key functional markers:<br><br>*   **Cell Cycle Regulation and Mitosis:**<br>    *   `MKI67`: A well-established marker of proliferating cells, present during all active phases of the cell cycle (G1, S, G2, and mitosis) but absent from resting cells (G0). Its high expression is a strong indicator of cell division.<br>    *   `CDK1` (also known as CDC2): A key cyclin-dependent kinase that regulates progression through the cell cycle, particularly the G2/M transition.<br>    *   `CCNB2` (Cyclin B2): A regulatory protein that associates with CDK1 and is essential for mitotic entry.<br>    *   `PLK1` (Polo-like kinase 1): A crucial regulator of multiple mitotic events, including centrosome maturation, bipolar spindle formation, and cytokinesis.<br>    *   `AURKB` (Aurora kinase B): A key component of the chromosomal passenger complex, essential for chromosome alignment, segregation, and cytokinesis.<br>    *   `TTK` (also known as MPS1): A kinase involved in the spindle assembly checkpoint (SAC), ensuring proper chromosome segregation.<br>    *   `NEK2`: A kinase involved in centrosome separation and maturation.<br>    *   `CDC25C`: A phosphatase that activates CDK1, promoting entry into mitosis.<br>    *   `NCAPG` (Non-SMC condensin I complex subunit G): A component of the condensin complex, involved in chromosome condensation.<br>    *   `PIMREG`: Involved in cell cycle progression and proliferation.<br>    *   `CDCA3`, `CDCA5`: Cell division cycle associated proteins, involved in cell cycle regulation.<br>    *   `PKMYT1`: A kinase that inhibits CDK1, involved in cell cycle control.<br>    *   `GTSE1`: Involved in cell cycle regulation and DNA damage response.<br>    *   `OIP5`: Involved in cell cycle progression.<br>    *   `FOXM1`: A transcription factor that regulates the expression of many genes involved in cell cycle progression and mitosis. Its high expression is characteristic of proliferating cells.<br>    *   `SKA1`, `SKA3`: Components of the outer kinetochore, essential for proper chromosome segregation.<br>    *   `NUF2`, `SPC24`, `SPC25`: Components of the NDC80 complex, a key part of the kinetochore.<br>    *   `KIF2C`, `KIF15`, `KIF18B`: Kinesin motor proteins involved in spindle dynamics and chromosome movement during mitosis.<br>    *   `CKAP2L`: Cytoskeleton-associated protein, potentially involved in spindle organization.<br>    *   `DLGAP5`: A scaffolding protein involved in spindle organization and cytokinesis.<br>    *   `CEP55`: Involved in cytokinesis.<br>    *   `TROAP`: Involved in cytokinesis.<br>    *   `DIAPH3`: Involved in cytokinesis.<br>    *   `IQGAP3`: Involved in cell proliferation and migration.<br><br>*   **DNA Replication and Repair:**<br>    *   `RRM2`: Ribonucleotide reductase M2 subunit, essential for dNTP synthesis, required for DNA replication.<br>    *   `TOP2A` (DNA topoisomerase II alpha): Involved in resolving DNA tangles and supercoils during replication and mitosis.<br>    *   `PCLAF` (PCNA-associated factor): Interacts with PCNA, involved in DNA replication and repair.<br>    *   `MND1`: Involved in homologous recombination and DNA repair.<br>    *   `POLQ` (DNA polymerase theta): Involved in DNA repair pathways.<br>    *   `GINS2`: A component of the GINS complex, essential for the initiation and elongation of DNA replication.<br>    *   `RAD51AP1`: Involved in homologous recombination and DNA repair.<br>    *   `CDT1`: Involved in DNA replication initiation.<br>    *   `TK1` (Thymidine kinase 1): Involved in the salvage pathway of dNTP synthesis.<br>    *   `CDC45`: A component of the CMG helicase complex, essential for DNA replication initiation and elongation.<br>    *   `CCNA2` (Cyclin A2): Involved in both DNA replication (S phase) and mitotic entry (G2 phase).<br><br>*   **Centromere and Chromosome Structure:**<br>    *   `HJURP` (Holliday junction recognition protein): Involved in the deposition of the centromeric histone variant CENPA.<br>    *   `CENPA` (Centromere protein A): A histone variant that marks centromeres and is essential for kinetochore assembly.<br>    *   `ASPM` (Abnormal spindle-like microcephaly associated): Involved in spindle pole integrity and mitotic progression.<br><br>*   **Ubiquitination:**<br>    *   `UBE2C` (Ubiquitin-conjugating enzyme E2 C): Involved in the ubiquitination and degradation of mitotic regulators, crucial for timely cell cycle progression.<br><br>*   **Other:**<br>    *   `PBK` (also known as TOPK): A kinase involved in various cellular processes, including cell cycle progression and proliferation.<br>    *   `DEPDC1`: Involved in cell cycle progression and proliferation.<br>    *   `ZNF695`: A zinc finger protein, its specific role in this context is less clear but may be related to transcriptional regulation of cell cycle genes.<br><br>**Step 2: List the Key Cell Type Markers**<br><br>Based on the provided list, there are no specific markers for differentiated cell types of the large intestine (e.g., enterocytes, goblet cells, enteroendocrine cells, immune cells, stromal cells). The markers are overwhelmingly related to cell cycle and proliferation.<br><br>**Step 3: Cross-reference Known Databases**<br><br>Searching databases like the Human Protein Atlas, PanglaoDB, and reviewing scRNA-seq literature on the large intestine confirms that the genes listed are highly enriched in proliferating cell populations. Specifically, markers like `MKI67`, `TOP2A`, `CDK1`, `CCNB2`, `RRM2`, and many of the kinetochore and spindle-associated proteins are canonical markers of actively dividing cells across various tissues, including the intestinal epithelium.<br><br>**Step 4: Determine the Most Probable General Cell Type**<br><br>Given the extremely high expression of a large number of genes directly involved in DNA replication, cell cycle progression, and mitosis, the most probable general cell type is **Proliferating Cells**.<br><br>**Step 5: Identify the Top 3 Most Probable Sub Cell Types**<br><br>Within the context of the large intestine, proliferating cells are primarily found in the crypts of the epithelium. These proliferating cells include:<br><br>1.  **Intestinal Stem Cells (ISCs):** These are the primary self-renewing cells in the crypts, responsible for generating all epithelial lineages. They are highly proliferative.<br>2.  **Transit-Amplifying (TA) Cells:** These are daughter cells of ISCs that undergo a limited number of rapid divisions before differentiating into various epithelial cell types. They are also highly proliferative.<br>3.  **Early Progenitor Cells:** While ISCs and TA cells are the main proliferative populations, early progenitor cells committed to specific lineages might still be undergoing some division before terminal differentiation.<br><br>Based on the markers provided, it is difficult to definitively distinguish between ISCs and TA cells solely on this list, as both populations are highly proliferative and express many of these cell cycle genes. However, the sheer breadth and intensity of the proliferation signature suggest a population undergoing rapid division.<br><br>Ranking the most probable sub cell types:<br><br>1.  **Transit-Amplifying (TA) Cells:** TA cells are characterized by rapid and extensive proliferation to expand the cell pool before differentiation. The strong and broad expression of proliferation markers aligns well with this population's function.<br>2.  **Intestinal Stem Cells (ISCs):** ISCs are also highly proliferative, but they also express markers related to stemness and self-renewal, which are not explicitly present in this list. However, their proliferative nature means they would express many of these genes.<br>3.  **Early Progenitor Cells:** While proliferative, their division rate might be lower than TA cells, and they would likely start expressing some lineage-specific markers, which are absent here.<br><br>Therefore, the most likely subtype based on this marker list is **Transit-Amplifying (TA) Cells**.<br><br>**Step 6: Provide a Concise Summary of Your Analysis**<br><br>The provided list of highly expressed genes from a single-cell cluster in human large intestine tissue is overwhelmingly enriched for markers of cell cycle progression, DNA replication, and mitosis, including canonical proliferation markers like MKI67, CDK1, CCNB2, and TOP2A. There is a notable absence of markers specific to differentiated intestinal epithelial lineages or other cell types found in the large intestine. This strong proliferative signature indicates that the cluster represents actively dividing cells. In the context of the large intestine epithelium, the most probable general cell type is Proliferating Cells. Within this category, the top three most probable sub cell types are Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs), and Early Progenitor Cells. Based on the extensive and rapid proliferative nature suggested by the marker list, Transit-Amplifying (TA) Cells are the most likely subtype.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Proliferating Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Transit-Amplifying (TA) Cells</li><li>Intestinal Stem Cells (ISCs)</li><li>Early Progenitor Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results provided are scientifically accurate and well-justified, demonstrating a strong understanding of the markers and their relevance to cell cycle and proliferation. The analysis correctly identifies the cluster as proliferating cells, which is supported by the overwhelming presence of markers like MKI67, CDK1, CCNB2, and TOP2A. The annotation also appropriately considers the context of the human large intestine, narrowing down the likely sub-cell types to Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs), and Early Progenitor Cells. <br><br>Strengths:<br>1. **Comprehensive Marker Analysis**: The annotation thoroughly groups and explains the functional roles of the markers, covering cell cycle regulation, DNA replication, mitosis, and other relevant processes. This demonstrates a balanced consideration of multiple markers rather than over-focusing on a single one.<br>2. **Contextual Relevance**: The annotation correctly places the markers in the context of the large intestine, identifying the crypt as the likely location of these proliferating cells.<br>3. **Sub-Cell Type Differentiation**: The annotation logically ranks the sub-cell types, with TA cells being the most probable, followed by ISCs and early progenitors. This reflects an understanding of the hierarchy and proliferation rates in the intestinal epithelium.<br>4. **Validation**: The annotation mentions validation passed, indicating that the results were cross-referenced with known databases, adding credibility.<br><br>Weaknesses:<br>1. **Lack of Stemness Markers**: While the annotation mentions ISCs, it does not explicitly address the absence of stemness markers (e.g., LGR5, ASCL2) that could further distinguish ISCs from TA cells. This could be a minor oversight.<br>2. **Marker Rank Consideration**: The annotation does not explicitly discuss the rank or expression levels of the markers, which could provide additional insights into the dominance of certain pathways or cell states. For example, the order of markers might hint at specific phases of the cell cycle being more active.<br><br>Overall, the annotation provides a comprehensive and accurate view of the cell populations, with only minor areas for improvement.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    